SCM Lifescience Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	37,307	38,704	77,366	175,143	233,826	586,015
Market Cap Growth	38.30%	-49.97%	-55.83%	-25.10%	-60.10%	-
Enterprise Value	28,409	40,480	65,415	170,464	217,178	551,155
Last Close Price	844.00	1891.00	3780.00	10694.08	14394.46	36522.70
PS Ratio	24.18	46.93	111.21	442.30	532.32	1831.26
PB Ratio	1.53	2.73	3.78	7.15	5.24	9.29
P/TBV Ratio	1.56	2.87	3.82	7.24	5.28	9.34
EV/Sales Ratio	18.41	49.08	94.03	430.49	494.42	1722.33
Debt / Equity Ratio	0.11	0.49	0.19	0.24	0.14	0.11
Net Debt / Equity Ratio	-0.36	0.43	-0.42	-0.13	-0.30	-0.45
Net Debt / EBITDA Ratio	1.21	-0.58	0.70	0.28	1.22	1.93
Net Debt / FCF Ratio	0.54	-0.43	0.69	0.27	0.96	2.32
Asset Turnover	0.06	0.03	0.02	0.01	0.01	0.01
Inventory Turnover	2.38	1.10	1.53	1.29	0.85	0.55
Quick Ratio	6.34	0.18	10.85	1.97	2.27	10.85
Current Ratio	6.61	0.35	11.55	2.20	2.33	11.07
Return on Equity (ROE)	-41.87%	-71.44%	-106.53%	-66.34%	-41.82%	-23.08%
Return on Assets (ROA)	-21.08%	-29.10%	-27.81%	-18.06%	-11.66%	-17.14%
Return on Capital Employed (ROCE)	-31.10%	-64.90%	-53.60%	-44.20%	-26.80%	-22.00%
Earnings Yield	-22.08%	-31.98%	-30.97%	-13.09%	-9.63%	-1.64%
FCF Yield	-44.37%	-36.50%	-15.99%	-6.67%	-6.02%	-2.11%
Buyback Yield / Dilution	-10.66%	-25.01%	-12.85%	-21.21%	-12.79%	-101.51%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.